secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001193125-23-196279
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma promotes Justin File to CFO; Brian Drazba departs without cause
--------------------------------------------------------------------------

- Justin J. File appointed CFO and Corporate Secretary effective August 1, 2023.
- Brian Drazba's employment as CFO terminated without cause on same date.
- Drazba receives severance of $428,635 (12 months base salary), COBRA subsidy for 12 months, and accelerated stock option vesting.
- Transition previously disclosed on June 13, 2023; Drazba remains through Separation Date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523196279/0001193125-23-196279-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523196279/d540602d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-196279

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer